Semaglutide SF (San Francisco, California)

Clinic Introduction

Semaglutide SF operates as a telehealth-focused weight loss clinic serving patients throughout San Francisco, California, with medical supervision of GLP-1 receptor agonist therapies. The clinic provides access to three FDA-approved medications—liraglutide, semaglutide, and tirzepatide—each prescribed based on individual metabolic profiles, weight loss goals, and medical history. Patients undergo initial consultations via secure video platform where providers review lab work, assess contraindications, and establish baseline metrics including body composition, fasting glucose, and lipid panels before initiating treatment. The clinic's treatment protocols center on GLP-1 receptor agonists that regulate appetite, slow gastric emptying, and improve insulin sensitivity. Liraglutide is typically prescribed as a daily subcutaneous injection starting at 0.6 mg with gradual titration to therapeutic doses, while semaglutide follows a weekly injection schedule beginning at 0.25 mg. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is reserved for patients requiring more robust metabolic intervention or those with concurrent type 2 diabetes. Each medication requires patient education on proper injection technique, refrigeration requirements, and management of common side effects including nausea and gastrointestinal adjustment during dose escalation phases. Semaglutide SF structures its programs around monthly telehealth check-ins where providers monitor weight trends, adjust dosing schedules, and address any adverse reactions or plateau periods. The clinic requires patients to submit updated weight logs and photographs for progress documentation, with lab work repeated at three-month intervals to track changes in hemoglobin A1C, liver enzymes, and thyroid function. Providers evaluate each patient's response to therapy and make medication switches when initial agents prove ineffective or poorly tolerated, ensuring continuity of care without requiring in-person office visits across the San Francisco Bay Area. Patients receive medication shipped directly to their San Francisco addresses in temperature-controlled packaging, with syringes, alcohol swabs, and sharps containers included in each monthly supply. The clinic provides written injection protocols and video demonstrations for first-time users of subcutaneous peptides, along with 24-hour messaging access for urgent questions about dosing errors or unexpected symptoms. Follow-up appointments address behavioral components of weight management, including meal timing strategies that complement GLP-1 mechanisms and exercise recommendations that preserve lean muscle mass during caloric deficit periods. The telehealth model eliminates geographic barriers for San Francisco residents in neighborhoods from the Marina to the Mission District, allowing patients to maintain treatment continuity despite work schedules or mobility limitations. Semaglutide SF accepts limited insurance plans for GLP-1 medications when prescribed for type 2 diabetes with BMI criteria met, while weight loss indications typically require out-of-pocket payment with transparent pricing disclosed during initial consultations. The clinic maintains a focused scope of practice centered exclusively on GLP-1 therapies rather than offering broad functional medicine services, ensuring provider expertise remains concentrated on peptide-based metabolic interventions and their specific monitoring requirements. The scope of services recorded for this clinic covers testosterone optimization for men experiencing low energy, reduced libido, changes in body composition, or sleep and mood shifts; medically supervised weight management, pairing prescription options with nutrition and lifestyle guidance rather than prescription alone. Practical details recorded for this location: the phone number on file is (415) 326-2201; the published hours are Friday: 8 AM-8 PM; Monday: 8 AM-8 PM; Sunday: 9 AM-5 PM; Tuesday: 8 AM-8 PM; Saturday: 9 AM-7 PM; Thursday: 8 AM-8 PM; Wednesday: 8 AM-8 PM; the clinic website on file is https://ongoweightloss.com. Patients travelling to San Francisco should confirm hours before a trip, because appointment times and operating schedules differ between locations in a multi-site practice. This entry covers the San Francisco location. Hormone and peptide therapy is a medical decision that should follow an evaluation and a discussion with a qualified clinician. Results vary between individuals, and no outcome is guaranteed. This profile is informational and does not replace medical advice.